Humanitas has also signed, at the hands of the scientific director of the Istituto Clinico...
In recent months, the new Centre for the Functional and Biological Reconstruction of the Knee,...
"Active Surveillance for Low Risk Non-muscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study...
Dr. Martina Molgora, a young researcher of Humanitas at the laboratory of experimental immunopathology of...
In Italy only 10% of the diagnoses of liver cancer occur at an early stage...
An Italian multicentre study, in which Humanitas also participated, confirms the role of Pentraxin3, a...
"Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a...
Among the speakers at Wired Health, the event organized last March 15 in Milan by...
Thousands of new cases every day in Italy alone and 500 deaths: these are the...
Ulcerative colitis is a chronic inflammatory disease that affects the rectum and may affect part...
Blood cancers, such as leukemia and lymphomas, are among the top ten causes of death...
For patients with a severe heart attack, adding a new generation anticoagulant drug (DOAC), now...
Professor Alberto Mantovani, Scientific Director of Humanitas, spoke in the Radio programme also broadcasted on...
The "TUDCA-ALS Kick-off meeting" will be held on Thursday 8 and Friday 9 February at...
Twins share DNA and are often studied because of their peculiarity. In Italy, the National...
An Italian study, directed and coordinated by Humanitas, funded by AIRC and published in Nature,...
Myelodysplastic syndromes or myelodysplasia are blood diseases that affect older people in particular. We talk...
